Caricamento...
Prostate cancer screening—when to start and how to screen?
Prostate-specific antigen (PSA) screening reduces prostate cancer (PCa) mortality; however such screening may lead to harm in terms of overdiagnosis and overtreatment. Therefore, upfront shared decision making involving a discussion about pros and cons between a physician and a patient is crucial. T...
Salvato in:
| Pubblicato in: | Transl Androl Urol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AME Publishing Company
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5861291/ https://ncbi.nlm.nih.gov/pubmed/29594018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2017.12.25 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|